Lung Cancer

1

Editorial Board

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 37 KB

english, 2010

2

A bibliometric analysis of scientific production in mesothelioma research

Ugolini, Donatella, Neri, Monica, Casilli, Cristina, Ceppi, Marcello, Canessa, Pier Aldo, Ivaldi, Giovanni Paolo, Paganuzzi, Michela, Bonassi, Stefano

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 262 KB

english, 2010

4

Surgical treatment of bronchial carcinoid tumors: A single-center experience

Machuca, Tiago Noguchi, Cardoso, Paulo Francisco Guerreiro, Camargo, Spencer Marcantonio, Signori, Leonardo, Andrade, Cristiano Feijó, Moreira, Ana Luiza Schneider, Moreira, José da Silva, Felicetti,

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 182 KB

english, 2010

5

Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: A phase I dose-escalation study

Reck, Martin, Frickhofen, Norbert, Cedres, Susana, Gatzemeier, Ulrich, Heigener, David, Fuhr, Heinz-Georg, Thall, Aron, Lanzalone, Silvana, Stephenson, Patricia, Ruiz-Garcia, Ana, Chao, Richard, Felip

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 210 KB

english, 2010

6

Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis

Olmez, Inan, Donahue, Bernadine R., Butler, James S., Huang, Yiwu, Rubin, Philip, Xu, Yiqing

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 116 KB

english, 2010

7

Copy number alterations and expression profiles of candidate genes in a pulmonary inflammatory myofibroblastic tumor

Jung, Seung-Hyun, Yim, Seon-Hee, Hu, Hae-Jin, Jung, Chan-Kwon, Lee, Sug-Hyung, Kim, Dong Hoon, Chung, Yeun-Jun

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 442 KB

english, 2010

8

Maintenance or consolidation therapy in small-cell lung cancer: A systematic review and meta-analysis

Rossi, Antonio, Garassino, Marina Chiara, Cinquini, Michela, Sburlati, Paola, Di Maio, Massimo, Farina, Gabriella, Gridelli, Cesare, Torri, Valter

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 521 KB

english, 2010

9

Histology classification is not a predictor of clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine or gemcitabine combinations

Trani, L., Myerson, J., Ashley, S., Young, K., Sheri, A., Hubner, R., Puglisi, M., Popat, S., O’Brien, M.E.R.

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 227 KB

english, 2010

10

Involvement of LKB1 in epithelial–mesenchymal transition (EMT) of human lung cancer cells

Roy, Badal C., Kohno, Takashi, Iwakawa, Reika, Moriguchi, Tetsuo, Kiyono, Tohru, Morishita, Kazuhiro, Sanchez-Cespedes, Montse, Akiyama, Tetsu, Yokota, Jun

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 922 KB

english, 2010

11

The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)

Lee, Jae Jin, Maeng, Chi Hoon, Baek, Seon Kyung, Kim, Gou Young, Yoo, Jee-Hong, Choi, Cheon Woong, Kim, Yee Hyung, Kwak, Young-Tae, Kim, Dae-Hyun, Lee, Young Kyung, Kim, Jung Bo, Kim, Si-Young

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 301 KB

english, 2010

12

Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancer

Um, Soo-Jung, Choi, Young Jin, Shin, Ho-Jin, Son, Cheol Hun, Park, You-Soo, Roh, Mee Sook, Kim, Yun Seong, Kim, Young Dae, Lee, Soo-Keol, Jung, Min Ho, Lee, Min Ki, Son, Choonhee, Choi, Pil Jo, Chung,

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 420 KB

english, 2010

13

Dose-escalation study of pemetrexed in combination with carboplatin followed by pemetrexed maintenance therapy for advanced non-small cell lung cancer

Okamoto, Isamu, Takeda, Koji, Daga, Haruko, Miyazaki, Masaki, Yonesaka, Kimio, Kiyota, Hidemi, Tsurutani, Junji, Ueda, Shinya, Ichikawa, Yasuko, Takeda, Masayuki, Sekiguchi, Risa, Tominaga, Kiyomi, En

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 118 KB

english, 2010

14

Subcarinal lymph node in upper lobe non-small cell lung cancer patients: Is selective lymph node dissection valid?

Aokage, Keiju, Yoshida, Junji, Ishii, Genichiro, Hishida, Tomoyuki, Nishimura, Mitsuyo, Nagai, Kanji

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 184 KB

english, 2010

15

Tumor histology affects the accuracy of clinical evaluative staging in primary lung cancer

Funakoshi, Yasunobu, Maeda, Hajime, Takeda, Shin-ichi, Nojiri, Takashi, Kawamura, Tomohiro

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 147 KB

english, 2010

16

Characterization of side population cells in human malignant mesothelioma cell lines

Kai, Kiyonori, D’Costa, Susan, Yoon, Byung-Il, Brody, Arnold R., Sills, Robert C., Kim, Yongbaek

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 395 KB

english, 2010

17

We should avoid vague conceptualisations and circular outcomes

Salander, Pär

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 72 KB

english, 2010

18

Complex rather than vague

Vos, Martina S., de Haes, Hanneke J.C.M.

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 64 KB

english, 2010

19

Exercise interventions following surgery for non-small cell lung cancer (NSCLC): The need for future randomised controlled trials

Granger, C., Denehy, L.

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

20

Involved field radiotherapy for locally advanced non-small cell lung cancer: Isolated mediastinal nodal relapse

Vanneste, B.G.L., Haas, R.L.M., Bard, M.P.L., Rijna, H., Váldes Olmos, R.A., Belderbos, J.S.A.

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 213 KB

english, 2010

21

Surgical resection of liver non-small cell lung cancer metastasis: A dual weapon?

Ileana, Ecaterina, Greillier, Laurent, Moutardier, Vincent, Barlesi, Fabrice

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 157 KB

english, 2010

22

Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity

Ku, Geoffrey Y., Chopra, Akhil, Lopes, Gilberto de Lima

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 121 KB

english, 2010

23

Corrigendum to “Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer” [Lung Cancer 69S1 (2010) S4–S10]

Journal:

Lung Cancer

Year:

2010

File:

PDF, 262 KB

2010

24

Corrigendum to “Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy” [Lung Cancer 69S1 (2010) S11–S18]

Journal:

Lung Cancer

Year:

2010

File:

PDF, 232 KB

2010

25

Efficacy of circulating plasma DNA as a diagnostic tool for advanced non-small cell lung cancer and its predictive utility for survival and response to chemotherapy

Kumar, Sachin, Guleria, Randeep, Singh, Vikas, Bharti, Alok C., Mohan, Anant, Das, Bhudev C.

Journal:

Lung Cancer

Year:

2010

Language:

english

File:

PDF, 183 KB

english, 2010

Volume 70; Issue 2

Editorial Board

Contents

A bibliometric analysis of scientific production in mesothelioma research

Surgical treatment of bronchial carcinoid tumors: A single-center experience

Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: A phase I dose-escalation study

Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis

Copy number alterations and expression profiles of candidate genes in a pulmonary inflammatory myofibroblastic tumor

Maintenance or consolidation therapy in small-cell lung cancer: A systematic review and meta-analysis

Histology classification is not a predictor of clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine or gemcitabine combinations

Involvement of LKB1 in epithelial–mesenchymal transition (EMT) of human lung cancer cells

The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)

Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancer

Dose-escalation study of pemetrexed in combination with carboplatin followed by pemetrexed maintenance therapy for advanced non-small cell lung cancer

Subcarinal lymph node in upper lobe non-small cell lung cancer patients: Is selective lymph node dissection valid?

Tumor histology affects the accuracy of clinical evaluative staging in primary lung cancer

Characterization of side population cells in human malignant mesothelioma cell lines

We should avoid vague conceptualisations and circular outcomes

Complex rather than vague

Exercise interventions following surgery for non-small cell lung cancer (NSCLC): The need for future randomised controlled trials

Involved field radiotherapy for locally advanced non-small cell lung cancer: Isolated mediastinal nodal relapse

Surgical resection of liver non-small cell lung cancer metastasis: A dual weapon?

Successful treatment of two lung cancer patients with erlotinib following gefitinib-induced hepatotoxicity

Corrigendum to “Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer” [Lung Cancer 69S1 (2010) S4–S10]

Corrigendum to “Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy” [Lung Cancer 69S1 (2010) S11–S18]

Efficacy of circulating plasma DNA as a diagnostic tool for advanced non-small cell lung cancer and its predictive utility for survival and response to chemotherapy